Zogenix reported $74.22M in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 158.93M 14.4M
Acura Pharmaceuticals ACUR:US 913K 123K
Adamas Pharmaceuticals ADMS:US 31.13M 2.29M
Aerie Pharmaceuticals AERI:US $ 58.69M 1.5M
Alnylam Pharmaceuticals ALNY:US $ 366.71M 2.89M
Arena Pharmaceuticals ARNA:US $ 144.39M 12.4M
AstraZeneca AZN:LN 7.09B 1.67B
Becton, Dickinson and BDX:US $ 4262M 231M
Biocryst Pharmaceuticals BCRX:US $ 79.54M 9.1M
Biogen BIIB:US $ 2289.3M 569.2M
Cardinal Health CAH:US 42.44B 3.64B
Esperion Therapeutics ESPR:US $ 73.19M 17.61M
Flexion Therapeutics FLXN:US $ 45.06M 2.67M
GlaxoSmithKline GSK:LN 6.42B 692M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Heron Therapeutics HRTX:US $ 82.91M 10.78M
Intra Cellular Therapies ITCI:US $ 89.19M 20.09M
Johnson & Johnson JNJ:US $ 16.65B 1.76B
Marinus Pharmaceuticals MRNS:US $ 25.39M 3.58M
Merk MRK:US $ 9905M 839M
Nektar Therapeutics NKTR:US $ 138.54M 5.5M
Neurocrine Biosciences NBIX:US $ 226.1M 21M
Pfizer PFE:US $ 13063M 3998M
Revance Therapeutics RVNC:US $ 89.14M 5.83M
Sarepta Therapeutics SRPT:US $ 331.66M 32.87M
Teva Pharmaceutical TEVA:IT 3.33B 220M
Zogenix ZGNX:US $ 74.22M 8.73M